Increasing Bioavailability for Oral/Solid Dosage Forms

Does your drug really need the needle? Senior Digital Editor Michele Vaccarello Wagner sits down with Merrion Pharmaceuticals CEO John Lynch at Trinity College Dublin to discuss the GIPET and GIRES technology for developing oral forms of drugs that were previously injection-based.